<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Netherlands</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Netherlands.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/nl.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Effectiveness of Omicron JN.1 vaccination against infection with JN.1-derived SARS-CoV-2 subvariants in a prospective cohort study in the Netherlands</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129030-f0002f3e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129030-f0002f3e/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The findings indicate that JN.1 vaccination provided limited additional protection against SARS-CoV-2 infection during a low-incidence period, with modest effectiveness observed in both age groups. The results contribute to understanding the real-world performance of updated COVID-19 vaccines against emerging subvariants.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Early Detection and Surveillance of the SARS-CoV-2 Variant BA.3.2 — Worldwide, November 2024–February 2026</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7510a1-514d0b54/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7510a1-514d0b54/</guid>
    <pubDate>Thu, 19 Mar 2026 00:00:00 GMT</pubDate>
    <description>Persistent monitoring remains necessary to evaluate whether genetic shifts could diminish immunity from past exposures or shots, especially considering the ongoing global disease burden.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Genomic epidemiology</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00545-6-9f0c6065/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00545-6-9f0c6065/</guid>
    <pubDate>Sun, 01 Feb 2026 00:00:00 GMT</pubDate>
    <description>The observed differences in immune durability between natural infection and vaccination highlight potential considerations for maintaining population-level protection against circulating orthopoxviruses.</description>
    <category>Smallpox</category>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Identifying key weather factors influencing human salmonellosis: A conditional incidence analysis in England, Wales, and the Netherlands.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2025-106410-57be0026/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2025-106410-57be0026/</guid>
    <pubDate>Wed, 15 Jan 2025 00:00:00 GMT</pubDate>
    <description>The conditional incidence method offers a transparent and readily applicable tool for characterizing weather-disease relationships in different geographic settings and weather scenarios, which may inform public health planning for salmonellosis prevention and control.</description>
    <category>Salmonellosis</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Cross-sectoral genomic surveillance reveals a lack of insight in sources of human infections with Shiga toxin-producing Escherichia coli, the Netherlands, 2017 to 2023</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-49-2400264-ecf69bd0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-49-2400264-ecf69bd0/</guid>
    <pubDate>Thu, 05 Dec 2024 00:00:00 GMT</pubDate>
    <description>The findings highlight gaps in identifying sources of human STEC infections despite existing monitoring programs. The decision to begin national-level STEC isolation aims to improve surveillance, source attribution, and guidance for monitoring and outbreak investigation.</description>
    <category>Gastroenteritis</category>
    <category>Genomic epidemiology</category>
    <category>Surveillance</category>
    <category>Climate and environment</category>
    <category>Travel medicine</category>
    <category>One Health</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Estimating the risk and spatial spread of measles in populations with high MMR uptake: Using school-household networks to understand the 2013 to 2014 outbreak in the Netherlands</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004466-7da89bf9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004466-7da89bf9/</guid>
    <pubDate>Tue, 08 Oct 2024 00:00:00 GMT</pubDate>
    <description>Clustering of unvaccinated children across primary and connected secondary schools can sustain sizable measles outbreaks even where national coverage exceeds 95%, suggesting that school-network structure is relevant for outbreak preparedness and response.</description>
    <category>Mumps</category>
    <category>Rubella</category>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-38-2400575-f7a0beb2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-38-2400575-f7a0beb2/</guid>
    <pubDate>Thu, 19 Sep 2024 00:00:00 GMT</pubDate>
    <description>The findings indicate that antibody responses to MVA-BN vaccination may not persist beyond one year, highlighting the need for ongoing surveillance to assess the public health implications of declining antibody levels for mpox outbreak preparedness.</description>
    <category>Smallpox</category>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2023-06-005-1cd69baa/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2023-06-005-1cd69baa/</guid>
    <pubDate>Sat, 01 Jul 2023 00:00:00 GMT</pubDate>
    <description>The findings demonstrate substantial population-level reduction in COVID-19 mortality through vaccination with no observed increase in non-COVID-19 mortality, providing evidence for the safety and effectiveness of COVID-19 vaccination programs.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccine</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2023-28-12-2200772-971f344b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2023-28-12-2200772-971f344b/</guid>
    <pubDate>Thu, 23 Mar 2023 00:00:00 GMT</pubDate>
    <description>The findings characterize a high-incidence mpox outbreak in a specific population and provide quantitative estimates of vaccine protection, contributing evidence relevant to vaccination strategy and risk communication for at-risk communities.</description>
    <category>Smallpox</category>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Travel medicine</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</guid>
    <pubDate>Fri, 01 Jul 2022 00:00:00 GMT</pubDate>
    <description>The registry addresses a recognized barrier in pandemic response by providing a centralized infrastructure to accelerate clinical trial recruitment across European countries, potentially shortening the timeline for vaccine and treatment development during infectious disease outbreaks.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-01-015-363843da/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-01-015-363843da/</guid>
    <pubDate>Tue, 01 Feb 2022 00:00:00 GMT</pubDate>
    <description>Despite existing vaccination programs targeting older adults and high-risk groups, substantial influenza burden persists in Europe. The findings suggest that combined strategies using improved vaccines for the elderly and universal pediatric vaccination may offer direct and indirect protection that is cost-effective across diverse European settings, supporting broader policy considerations for seasonal influenza control.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Dot map cartograms for detection of infectious disease outbreaks: an application to Q fever, the Netherlands and pertussis, Germany</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-26-30562-23bed950/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-26-30562-23bed950/</guid>
    <pubDate>Thu, 29 Jun 2017 00:00:00 GMT</pubDate>
    <description>Dot map cartograms may support outbreak detection and visualization by public health professionals, facilitating informed decisions for investigation and control activities.</description>
    <category>Pertussis</category>
    <category>Q fever</category>
    <category>COVID-19</category>
    <category>Surveillance</category>
    <category>One Health</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Modelling the risk of transfusion transmission from travelling donors</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-016-1452-z-5dc9a5e3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-016-1452-z-5dc9a5e3/</guid>
    <pubDate>Fri, 01 Apr 2016 00:00:00 GMT</pubDate>
    <description>The model provides decision-makers with quantitative estimates of past versus future transfusion transmission risk from traveling donors, supporting evidence-based decisions about public communication and blood safety interventions during emerging disease outbreaks.</description>
    <category>Chikungunya</category>
    <category>Q fever</category>
    <category>Travel medicine</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2015-11-060-218332a8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2015-11-060-218332a8/</guid>
    <pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
    <description>The findings suggest carriage surveillance can assess vaccine effects on circulating pathogens, evaluate pneumococcal conjugate vaccine impact, and predict changes in respiratory and invasive disease. A potential new equilibrium between non-vaccine pneumococcal serotypes and other pathogenic bacteria may be emerging in the post-PCV era.</description>
    <category>Haemophilus influenzae</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Underdiagnosis of Foodborne Hepatitis A, the Netherlands, 2008–20101</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2004-130753-45c4bd7b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2004-130753-45c4bd7b/</guid>
    <pubDate>Tue, 01 Apr 2014 00:00:00 GMT</pubDate>
    <description>The article is relevant to outbreak recognition and surveillance methods for hepatitis A, especially where routine systems may miss food-associated cases. It frames the work as important for understanding how a complex food market may affect detection outside endemic settings.</description>
    <category>Hepatitis A</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-04-15589-x-ae928ecf/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-04-15589-x-ae928ecf/</guid>
    <pubDate>Sun, 01 Feb 2004 00:00:00 GMT</pubDate>
    <description>The authors highlight the importance of adequate surveillance, outbreak preparedness, and pandemic planning, given the unexpectedly high number of zoonotic transmissions and evidence of person-to-person spread.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
  </item>
  <item>
    <title>Antigenic drift in swine influenza H3 haemagglutinins with implications for vaccination policy</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s0264-410x-98-00392-2-6f364c55/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s0264-410x-98-00392-2-6f364c55/</guid>
    <pubDate>Mon, 01 Mar 1999 00:00:00 GMT</pubDate>
    <description>The observed antigenic divergence between circulating swine H3N2 viruses and existing vaccine strains highlights the importance of matching veterinary vaccines to currently circulating strains to maintain effective protection in pig populations.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Outbreak investigation</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
</channel>
</rss>
